title: Workshop I: Parkinson's disease and sleep--results of the group discussion.
abstract: The group agreed on the facts that unwanted sleep onset has been observed after non-ergot as well as ergot dopamine agonists, that patients on these drugs need to be warned, that patients who have experienced sleepiness already must not drive a car unless the dosage is lowered and sleepiness has vanished, that a genetic predisposition for narcoleptic cataplexy has to be ruled out, that predictors of so-called sleep attacks need to be explored individually with the help of sleepiness scales and collectively in a careful study, respectively.
authors.affiliation: Dept. of Neurology, Ev. Johannes-Hospital, Bielefeld, Germany.
authors.forename: P
authors.initials: P
authors.lastname: Clarenbach
authors.forename: W
authors.initials: W
authors.lastname: Greulich
authors.forename: H M
authors.initials: HM
authors.lastname: Meinck
authors.forename: B
authors.initials: B
authors.lastname: Rathey
authors.forename: H
authors.initials: H
authors.lastname: Schipper
authors.forename: L
authors.initials: L
authors.lastname: Lachenmayer
authors.forename: M
authors.initials: M
authors.lastname: Werner
mesh_terms: D015984:Causality; D002985:Clinical Protocols / Q000592:standards; D015259:Dopamine Agents / Q000009:adverse effects*; D004493:Education; D006801:Humans; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy*; D018579:Patient Selection; D012893:Sleep Wake Disorders / Q000139:chemically induced* / Q000145:classification / Q000503:physiopathology
chemical_list: D015259:Dopamine Agents